These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 7692147)
1. The management of hypertension and associated risk factors for the prevention of long-term cardiac complications. Houston MC J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S2-13. PubMed ID: 7692147 [TBL] [Abstract][Full Text] [Related]
2. Hypertension and coronary heart disease risk factor management. Houston MC Clin Auton Res; 1993 Dec; 3(6):357-61. PubMed ID: 8193521 [TBL] [Abstract][Full Text] [Related]
3. New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension. Houston MC Am Heart J; 1989 Apr; 117(4):911-51. PubMed ID: 2648781 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of antihypertensive drugs on hypertension: associated risk factors. Weidmann P Cardiology; 1994; 85 Suppl 1():78-83. PubMed ID: 7743540 [TBL] [Abstract][Full Text] [Related]
5. New insights and approaches to reduce end-organ damage in the treatment of hypertension: subsets of hypertension approach. Houston MC Am Heart J; 1992 May; 123(5):1337-67. PubMed ID: 1575152 [TBL] [Abstract][Full Text] [Related]
6. Hypertension and coronary heart disease risk factor management. Houston MC Aust Fam Physician; 1994 Feb; 23(2):243-5, 248-51. PubMed ID: 8161313 [TBL] [Abstract][Full Text] [Related]
7. Management of hypertension in patients with enhanced cardiovascular risk. Introduction. White WB Am J Med; 2008 Aug; 121(8 Suppl):S1. PubMed ID: 18638613 [No Abstract] [Full Text] [Related]
8. Hypertensive heart disease--significance of left ventricular hypertrophy. Schmieder RE J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190 [TBL] [Abstract][Full Text] [Related]
9. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease. Bangalore S; Fayyad R; Laskey R; Demicco DA; Deedwania P; Kostis JB; Messerli FH; Am J Med; 2014 Jan; 127(1):71-81.e1. PubMed ID: 24210549 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease. Strauer BE Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004 [TBL] [Abstract][Full Text] [Related]
11. Is high blood pressure a late manifestation of the hypertension syndrome? Neutel JM; Smith DH; Weber MA Am J Hypertens; 1999 Dec; 12(12 Pt 3):215S-223S. PubMed ID: 10619574 [TBL] [Abstract][Full Text] [Related]
12. [Drugs and arterial stiffness in hypertensive patients]. Laurent S Drugs; 2003; 63 Spec No 1():1-8. PubMed ID: 12708878 [TBL] [Abstract][Full Text] [Related]
13. A cardioprotective approach to the management of hypertension. Kaplan NM J Hypertens Suppl; 2000 Jul; 18(3):S29-31. PubMed ID: 10952085 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular outcomes of treating high blood pressure. Weber MA Am Heart J; 1987 Oct; 114(4 Pt 2):964-71. PubMed ID: 3310572 [TBL] [Abstract][Full Text] [Related]
16. Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists. Vogt M; Strauer BE Am J Cardiol; 1995 Nov; 76(13):24D-30D. PubMed ID: 7495214 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of myocardial and coronary effects of arterial hypertension]. Strauer BE; Motz W; Vogt M Z Kardiol; 1989; 78 Suppl 7():231-8. PubMed ID: 2533767 [TBL] [Abstract][Full Text] [Related]
18. The Role of Beta-Blockers in the Treatment of Hypertension. Cruickshank JM Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711 [TBL] [Abstract][Full Text] [Related]